Gina Ross Murdoch By Gina Ross Murdoch MSAA President and CEO With our previous fiscal year wrapping up in the summer, I am excited to share some of MSAA’s highlights […]
Read News ArticleAuthor: Hoff Communications
The Motivator – Summer/Fall 2018
View/Download PDF View Digital Edition Cover Story Revealing the Mysteries behind Magnetic Resonance Imaging By Jill Conway, MD, MA, MSCE An overview of the MRI for individuals with MS – […]
Read News ArticleWhat’s New in MS Research: September 2018
Research into the causes, diagnosis, impact, and management of multiple sclerosis (MS) continues to move forward on a broad front and at a rapid pace. While many advances are announced at medical meetings, such as the annual gatherings of the American Academy of Neurology (AAN), American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Consortium of Multiple Sclerosis Centers (CMSC), and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), other findings are reported in medical journals throughout the year.
Read News ArticleEmergency Preparedness Resources
In the event of a disaster in your area, make sure you can access emergency services.
Read News ArticleYoga and MS: Start Where You Are
In this archived webcast, yoga therapist Kimberly Castello explores how breathing and therapeutic movements can be integrated into one’s daily routine to reduce stress, while increasing energy, mobility, and strength. […]
Read News ArticleIn Memory of Robert Rapp
The entire staff at the Multiple Sclerosis Association of America (MSAA), as well as many of MSAA’s corporate partners, are mourning the loss of our former Chief Operating Officer and […]
Read News ArticleFDA Accepts Application for Cladribine Tablets
EMD Serono, Inc. announced today that the United States Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for Cladribine Tablets (an oral formulation of cladribine), an […]
Read News Article